Rank 14 of 31

EIC Accelerator winners in Norway

17 companies from Norway won 18 EIC Accelerator awards, 2% of all winners.
17
Companies
18
Awards
#14
Rank by winners
16
Checked by Rasph
16
Deep dives
2%
Share of all winners

Funding mix

  • Blended finance11
  • Grant first5
  • Grant only1
  • Equity only1

What happened to them (16 of 17 checked)

  • Active14
  • Acquired1
  • Insolvent1
  • Not yet checked1

All 17 winners from Norway

EIC Accelerator winners in Norway
CompanyProjectCut-offFundingStatusRasph
NADENO NANOSCIENCE ASPACAndTreatTransformative nanotechnology drug delivery platform enabling eradication of micrometastases in ovarian cancerOctober 2025Blended financeNot yet checked
KITEMILL ASAWE-KM2Airborne Wind Energy: Innovative KM2 AWE System by KitemillMarch 2024Blended financeActiveDeep dive
DoMore Diagnostics ASHistotype PxPrecision biomarker based on digital pathology and artificial intelligence to guide fast and cost-effective personalized treatment decision support for colorectal cancer patientsNovember 2023Blended financeActiveDeep dive
Ocean Visuals ASOWLHyper-Spectral Laser Induced Fluorescence LiDAR to detect Submerged Oil over Water in real-time on a molecular level.November 2023Blended financeActiveDeep dive
Nanopower ASNANOPOWERIntelligent power management integrated circuits for a greener, more efficient Internet of ThingsJune 2023Blended financeActiveDeep dive
Excess Engineering ASElectric Actuator (The missing link)Electrification of heavy machineryMarch 2023Blended financeActiveDeep dive
PICTERUS ASPicterus Jaundice mHealth platformBringing newborn care home: An integral mHealth solution for neonatal jaundice management.March 2023Grant firstActiveDeep dive
IRIS AI ASThe Digital R&D team memberA Digital R&D team member, automating scientific knowledge handling, allowing European R&D to increase their speed of innovationOctober 2022Blended financeActiveDeep dive
GlucoSet ASMAGICMinimally invasive reliAble Glucose monitoring in Intensive CareJune 2022, May 2026Blended financeActiveDeep dive
Hemispherian ASCureGLIOClinical validation of GLIX1: a small molecule that targets epigenetic changes in cancer cells to treat glioblastoma multiforme (GBM), the highest global unmet need in oncology.June 2022Blended financeActiveDeep dive
Oivi ASiScanAutomated retinal scans for early detection of diabetic eye diseases through use of artificial intelligenceJune 2022Grant firstActiveDeep dive
Invivo Bionics ASPRESSUROA life-changing PREssure Sensor System for UROdynamics to solve global urinary storage and voiding problemsMarch 2022Grant firstActiveDeep dive
CELERWAY COMMUNICATION ASCelerway GO miniCelerway GO mini, your office network in your pocketOctober 2021Grant onlyActiveDeep dive
DigiFarmCropCloudDetecting the world's most accurate field boundariesOctober 2021Blended financeAcquiredDeep dive
Ocean Oasis ASReWaterOffshore renewable and clean desalination of sea waterOctober 2021Grant firstActiveDeep dive
Bluegrove ASBluegrove Welfare ShieldSustainable seafood productionJune 2021Grant firstActiveDeep dive
N2 APPLIED ASSmartNitroFarm Scale-upRenewable fertiliser from airJune 2021Equity onlyInsolventDeep dive